MedTrace Logo

Stem Cell Therapy: a Compassionate Use Program in Perianal Fistula

NCT03726255 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2018-11-13

No results posted yet for this study

Summary

This observational study aims at assessing the safety and efficacy profiles of mesenchymal stem cell, in different formats (SVF, autologous, allogenic), to treat complex perianal fistula according to the Spanish national Compassionate-use law .

Conditions

  • Perianal Fistula

Interventions

PROCEDURE

Mesenchymal Stem Cell injection

curettage, closure of the internal opening (IO) and cell injection in IO (50%) and fistula tract (50%)

Sponsors & Collaborators

  • Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

    lead OTHER

Principal Investigators

  • Damian Garcia-Olmo, Prof. · Instituto de Investigación Sanitaria Fundación Jiménez Díaz

Eligibility

Min Age
24 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-01
Primary Completion
2018-01-26
Completion
2018-07-26

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03726255 on ClinicalTrials.gov